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doi:10.1016/j.ejvs.2009.11.018Abstract Objectives: Aortoiliac aneurysms comprise up to 43% of the specialist endovascular
caseload. In such cases endovascular aneurysm repair (EVAR) requires distal extension of the
aortoiliac endograft beyond the ostium of the internal iliac artery (IIA) and into the external
iliac artery, conventionally necessitating the embolisation of one or both IIA. This has been
associated with a wide range of complications, and the use of an Iliac Branch-graft Device
(IBD) offers an appealing endovascular solution.
Design: Medline, trial registries, conference proceedings and article reference lists were
searched to identify case series reporting IBD use. Data were extracted for review.
Results: Nine series have reported the use of IBD in a total of 196 patients. Technical success
was 85e100%. Median operating times were 101e290 min and median contrast dose was
58e208 g, with no aneurysm-related mortality. Claudication developed in 12/24 patients after
IBD occlusion. One type I endoleak and two type III endoleaks occurred and were managed
endovascularly. Re-occlusion occurred in 24/196 patients.
Conclusion: IBD was performed with high technical success rates and encouraging mid-term
patency. Formalised risk stratification andmorphological data are required to identify the group
of patients who will benefit most. Cost-effectiveness appraisals are needed for this technique.
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Figure 1 Angiogram to illustrate cannulation of right IIA from
the left femoral artery, using a pre-loaded wire from the IIA
side branch of the Zenith Bifurcated Iliac Side (ZBIS) device
(Cook Inc., Bloomington, IN).
286 A. Karthikesalingam et al.Introduction
The evolution of endovascular techniques has increased the
proportion of patients with abdominal aortic aneurysm (AAA)
suitable for treatment by endovascular aneurysm repair
(EVAR) in addition to open repair. However, the proximal or
distal extension of aneurysmal disease to visceral or iliac
branches of the aorta increases the complexity of EVAR and
its consequent morbidity and mortality.1
Although isolated iliac aneurysms are rare,2 aortoiliac
aneurysms comprise a significant proportion of the
specialist vascular caseload. Unilateral common iliac artery
(CIA) aneurysms are present in 43%, and bilateral CIA
aneurysms in 11% of patients with intact AAA;3 In such cases
EVAR requires distal extension of the aortoiliac endograft
beyond the ostium of the internal iliac artery (IIA) and into
the external iliac artery (EIA), conventionally necessitating
the embolisation of one or both internal iliac arteries (IIA).
Sacrifice of the IIA in this manner has been associated with
a wide range of complications. These predominantly
comprise buttock claudication4,5 and erectile dysfunction6
but may even include bowel or spinal ischaemia,7 sloughing
of the scrotal skin8 or ischaemic injury to the lumbosacral
plexus.9
Sequelae of Sacrificing the Internal Iliac
Artery: Supply and Demand
The severity of symptoms following the sacrifice of one or
both IIA is affected by the demand of end organs in the
vascular territory of the IIA, as well as their collateral
supply. Younger, more active patients have a greater
demand for blood supply and a significantly higher risk of
buttock claudication after IIA occlusion, and those with
poor supply due to reduced cardiac output are also at high
risk.10 Collateral blood supply is derived from the contra-
lateral IIA and bilaterally from profunda femoris and
external iliac branches.11 Although it is logical to presume
that bilateral IIA occlusion would be associated with
a greater risk of complications due to pelvic ischaemia, the
published evidence suggests that there is no increase in risk
compared to unilateral IIA occlusion.12 A systematic liter-
ature review identified the development of buttock clau-
dication in 31% of patients who underwent unilateral IIA
embolisation prior to EVAR and in 35% of patients with
bilateral IIA embolisation prior to EVAR.12 New onset erec-
tile dysfunction was reported in 17% of patients undergoing
unilateral IIA embolisation prior to EVAR and in 24% of
patients undergoing bilateral IIA embolisation prior to
EVAR.12 Publication bias is likely to exert a significant effect
and such findings must be interpreted with caution.
Furthermore, the rate of major complications occurring as
a result of bilateral IIA occlusion is probably under-repor-
ted. However, there is no evidence for benefit from the
sequential rather than simultaneous sacrifice of bilateral
IIA.13 Interruption of the IIA as proximally as possible
reduces ischaemic complications and it is likely that this is
due to greater preservation of collateral blood supply.4,13
However, the importance of significant publication bias in
the reporting of pelvic complications following IIA occlusion
must be emphasised.Alternatives to IIA Sacrifice
The group of patients at greatest risk from sacrifice of the IIA
remains largely unidentified. Although complications from
bilateral IIA sacrifice are relatively innocuous in some series,4
persistent and debilitating buttock claudication is seen in
other series after unilateral IIA occlusion.12 There are many
confounding factors in the literature to explain such hetero-
geneity, including differences in the prevalence of diabetes,
variations in population age, the length of follow-up and the
small sample size of existing studies. Nevertheless, some
(as yet undefined) groupsof patients at high risk of developing
complications might benefit from preservation of IIA flow.
Techniques described for preservation of the IIA include
relocation of the IIA origin,14 IIA bypass,15 bell-bottom
grafts,16 and external-to-internal iliac stent-grafts with
femoro-femoral cross-over.17e19 In comparison to thesemore
invasive techniques, the use of Internal Iliac Branch-Graft
Devices (IBDs) offers an appealing endovascular solution.
Iliac Branch Devices
IBDs extend from a conventional EVAR stent-graft in to the
EIA whilst preserving flow in to the ipsilateral IIA using
a side branch. The IIA is cannulated from the contralateral
femoral artery using a pre-loaded wire from the side branch
(Fig. 1).
Two systems have been reported in current use: the
Zenith Bifurcated Iliac Side (ZBIS) device (Cook Inc., Bloo-
mington, IN, USA) (Fig. 2) and the Helical Branch Endograft
(HBE) device described by Greenberg et al20 (Fig. 3) avail-
able for commercial use (Cook Inc., Bloomington, IN).
Figure 2 Photograph of the Zenith Bifurcated Iliac Side (ZBIS)
device (Cook Inc., Bloomington, IN) illustrating the straight side
branch for preservation of the internal iliac artery (IIA). Figure 3 Photograph of the Helical Branch Endograft (HBE)
developed by Greenberg et al incorporating a directional side-
branch for preservation of the IIA.
EVAR with Iliac Branch-Graft Device 287Methods
An electronic search was performed using the Embase and
Medline databases from 1966 until 1 September, 2009. The
search terms ‘‘EVAR’’, ‘‘Hypogastric artery’’, ‘‘Internal Iliac
Artery’’ and ‘‘Branch Graft’’ were used in combination with
the Boolean operators AND or OR. The electronic search was
supplemented by a hand search of published abstracts from
meetings of the Veith Symposium, the International
Symposium on Endovascular Therapy (ISET), Euro-PCR, the
European Society of Vascular Surgery (ESVS), the British
Society of Endovascular Therapy (BSET), the Society for
Vascular Surgery (SVS) and the Vascular Society of Great
Britain and Ireland. The reference lists of articles obtained
were also searched to identify further relevant citations.
Finally, the search included the Current Controlled Trials
Register (www.controlled-trials.com) and the Cochrane
Database of Controlled Trials. IBD reports containing fewer
than 5 patients were excluded unless supplementary data
from a greater number of patients were available following
personal communication. Data were extracted for review,
using consensus definitions for reporting outcomes after
EVAR.21
Results and Discussion
There have been 8 published series20,22e28 reporting the use
of IBD. Following personal communication (authors A.K.and J.B.), data from one unpublished series were obtained,
which incorporated previously published data29 (Cambridge
Vascular Unit, Cambridge University Hospitals NHS Founda-
tion Trust, UK). In total, 9 series of patients undergoing IBD
were therefore included for review. An earlier article has
previously reviewed 5 of these 9 series.30 One of the series
not previously reviewed incorporated the first comparative
study of IBDwith IIA occlusion.27 Twopairs of reports by Dias/
Malina22,24 and Greenberg/Haulon20,23 included the same
patients; therefore only the most recent data were
reviewed. This resulted in the review of 7 unique case series
reporting the use of IBD in a total of 196 patients.
Indications for use and patient selection
A wide range of morphological and clinical indications for
use was found across the included series (Table 2). In
patients with two patent IIA prior to IBD, Tielliu et al
adopted minimum exercise tolerance criteria for IBD
selection to exclude those who had a limited level of
activity.26 In patients with only one patent IIA prior to
consideration for an IBD, Tielliu et al did not employ
exercise tolerance as a selection criterion. In all series, at
least 19 of 196 patients undergoing IBD underwent occlu-
sion of the contralateral IIA (Table 1).
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288 A. Karthikesalingam et al.Standardisedmorphological criteria for theuse of IBD have
not been defined or validated. Objective criteria required for
patients to receive an IBD included the presence of an aneu-
rysmal CIA of diameter>24 mm,27,28 the presence of a patent
CIA lumen greater than 18 mm26 or 20 mm,27 an adequate
length of EIA for distal landing of>20 mm25 or>15 mm,27 and
sufficient length of IIA of>10 mm22,25,27 to secure the branch
device. It has been stated that the IIA must ideally be of
‘‘normal diameter’’25 or up to 11 mm in diameter22 to receive
the IBD device. Although patients with aneurysmal IIA were
excluded from some series,26 this challenging anatomy was
tackled in other series using IBD25,27,29 (Table 3). Increasing
experience with the IBD will permit the derivation and
stratification of morphological risk factors for device failure,
to improve patient selection for this new technique.
Excluding patients whowere rejected for non-anatomical
reasons on clinical grounds alone, 52% (27/52) of patients
with aortoiliac or solitary iliac aneurysms assessed by Tielliu
et al,26 were deemed anatomically suitable to receive IBD.
The external validity of this anatomical application rate
requires further investigation, as there is a paucity of liter-
ature to assess the proportion of patientswith CIA aneurysms
who are morphologically suitable for IBD.Technical success
There was no significant difference in technical success rate
between IBD deployment and IIA embolisation in the single
comparative study of these techniques.27 The rate of tech-
nical success varied between 85% and 100% for modern IBDs
in current use (Table 4). This demonstrates the feasibility of
IBD use in a selected group of patients. The technical success
rate has been shown to improve with time, secondary to the
learning curve associated with IBD deployment and the
development of second-generation modular IBDs following
withdrawal of the first-generation unibody IBD.28 A range of
bridging stents was used across different series (Table 4) and
there has been no comparative analysis to determine if this
affects outcome. As expected for a novel technique, there
was a wide range of median operating times (101e290 min)
and median contrast dose (58e208 g) across all series. This
partly reflected heterogeneity in the operations reported,
which ranged from bilateral IBD with simultaneous fenes-
trated EVAR to solitary CIA aneurysm repair.
Intraoperative IIA dissection occurred in two patients. The
first of these dissections was caused by technical difficulty in
a female patient with a small IIA23 and the second occurred
due to operator error after excessive dilatation of the
balloon-expandable IIA stent-graft.22
It has been reported that difficulty in negotiating the
cross-over of the aortic bifurcation can lead to technical
failure. Difficulty in negotiation of the aortic cross-over is
a particular concern in patients undergoing IBD as
a secondary procedure after initial aorto-bi-iliac EVAR.26,28 In
this setting, a brachial or axillary approach may be used for
IIA cannulation.28 Where necessary, a brachial approach was
employed in all the studied series (Table 4), despite exposing
patients to a potential risk of stroke. However, this was not
reported in any of the patients requiring brachial or axillary
access. Overall, IBD deployment was associated with a low
rate of post-operative medical complications and there was
Table 2 Inclusion criteria for IBD series.
Author, year Morphological inclusion criteria Clinical inclusion criteria
Dias/Malina et al 2008/200623,25 IIA diameter <11 mm
IIA length >10 mm
None specified
Haulon/Greenberg et al, 2007/200621,24 None specified None specified
Ziegler et al, 200729 CIA diameter >24 mm
Difficulty with: intraluminal CIA thrombus,
severe EIA kinking, stenosis of IIA ostium,
>500 IIA offspring
None specified
Serracino-Inglott et al, 200726 IIA calibre ‘‘normal’’
IIA length > 10 mm
EIA>20 mm length
EIA diameter 8e11 mm
None specified
Tielliu et al, 200927 Patent CIA lumen >18 mm
(free of intraluminal thrombus)
Relative contra-indications:
sharp aortic bifurcation, iliac tortuosity
Non-aneurysmal IIA
IIA not heavily stenotic
Level of activity:
If contralateral IIA patent,
patient had to walk one
block to get IBD
If contralateral IIA occluded,
activity level not considered
Verzini et al, 200928 CIA diameter >24 mm
Patent CIA lumen >20 mm
CIA length >40 mm
IIA length >10 mm
EIA length >15 mm
None specified
Cambridge Vascular Unit
(unpublished), 2009
None specified None specified
EVAR with Iliac Branch-Graft Device 289only 1 TIA and 1 subarachnoid haemorrhage in the series
reported, with 0% aneurysm-related mortality (Table 5).
Clinical success
Only one patient who underwent successful implantation of
an IBD experienced buttock claudication.27 By intention-to-
treat analysis, clinical success rates varied from 63% to 88%
within the follow-up range of the 7 studies included in
review. There were 24 IBD occlusions across 196 patients in
all series. Occluded IBDs did not cause aneurysm rupture or
sac expansion. However, there remains a significant rate of
device failure, and therefore a degree of caution should be
exercised in patient selection for IBD.
Amongst 24 patients in whom post-operative IBD
occlusion followed the attainment of initial technical
success, 50% (12/24) manifested symptomatic buttock
claudication (Table 5). The low rate of symptomsTable 3 Extension of aneurysm disease (%, *not exclusive).
Author, year IBD as Secondary
Procedure
Dias/Malina et al, 2008/200623,25 4.3
Haulon/Greenberg et al, 2007/200621,24 e
Ziegler et al, 200729 8.7
Serracino-Inglott et al, 200726 12.5
Tielliu et al, 200927 e
Verzini et al, 200928 e
Cambridge Vascular Unit, 2009 efollowing IBD occlusion adds weight to the importance of
case selection for IBD. Across all the studies, factors
associated with technical difficulty predisposing to IBD
occlusion included a sharp aortic bifurcation, iliac tortu-
osity or calcification, the presence of intraluminal CIA
thrombus, severe EIA kinking, stenosis of the IIA ostium,
IIA atherosclerosis or IIA aneurysm. Cases of post-opera-
tive IBD occlusion were managed with a range of tech-
niques. Most IBD occlusions were managed conservatively,
one of which recanalised spontaneously.28 One case of IBD
occlusion was managed successfully with thrombolysis28,
one case was managed with femoro-femoral cross-over.22
In two cases of IBD occlusion, EVAR was converted to open
repair, IBD explantation and open aorto-bi-iliac recon-
struction without IIA revascularisation.28
There was a low endoleak rate, with only 1 type I
endoleak and 2 type III endoleaks across all series (Table 5).
All type II endoleaks were managed conservatively, as noneAAAþ CIA
aneurysm
Solitary CIA
aneurysm
*IIA aneurysm
60.7 35 e
80 20 e
73.9 17.4 e
75 e 12.5
74 26 e
78 12 19
88 12 25
Table 4 Outcomes in patients with IBD.
Author, year Mortality
% (n)
Technical
success
% (n)
Initial clinical
success
(<30 days)
% (n)
Short-term
clinical success
(30 dayse6
months) % (n)
Mid-term
clinical
success
(6 monthse
5 years) % (n)
Operating
time (min)
Iodine
dose
IIA bridging
stent-grafta
Additional
adjuncts
deployed
in IIAa
Brachial or
axillary
access
required
Dias/Malina et al,
2008/200623,25
9.1% (2/22)
0 aneurysm-
related
91.3%
(21/23)
2 IBD
occlusions
87% (20/23)
1 IBD occlusion
83% (19/23)
1 IBD occlusion
74%
(17/23)
2 IBD
occlusions
279
(234e327)
58 (48e78) Advanta
V12 (10)
Jomed (6)
Fluency
Plus (7)
Advanta
V12 (3)
Jomed stent-
graft (2)
AVE stent (1)
Luminexx (1)
1/22
Haulon/
Greenberg
et al, 2007/
200621,24
13% (7/52)
0 aneurysm-
related
94%
(49/52)
2 unable
to visualise
IIA1 unable
to cross aortic
bifurcation
79% (41/52)
6 IBD
occlusions
(2 EIA
thrombosis)
79% (41/52)
0 further
complications
79% (41/52)
0 further
complications
e 208 Fluency
Plus
Advanta
V12 (2)
Genesis
expandable
Common
(exact no.
not stated)
Ziegler
et al, 200729
1st Generation
Unibody IBD:
0 62% (16/26) 72% (33/46)
0 further
complications
63% (29/46)
4 IBD occlusions
63% (29/46)
0 further
complications
183
(100e330)
88
(35e180)
Not
described
Not described Exact no.
not stated
2nd Generation
IBD:
0 85% (17/20) Not
described
Not described
Serracino-Inglott
et al, 200726
0 100% (8/8) 88% (7/8)
1 IBD occlusion
88% (7/8)
0 further
complications
88% (7/8)
0 further
complications
101
(84e130)
103
(84e130)
Advanta
V12 (8)
e 1/8
Tielliu
et al, 200927
11.1% (3/27)
0 aneurysm-
related
96% (26/27) 86% (18/21)
3 IBD occlusions
185  31 e Advanta
V12 (23)
Jomed (3)
e 2/27
Verzini
et al, 200928
3% (1/32) 0
aneurysm-
related
94% (30/32)
2 IBD occlusions
153
(no range
or s.d.)
e Advanta
V12 (19)
Fluency (13)
‘‘Self-expanding
stent’’ (5)
2nd Fluency
stent (1)
Not stated
Cambridge
Vascular Unit
(unpublished),
2009
0 75% (6/8)
2 IBD occlusions
290
(230e390)
e Advanta
V12 (6)
e 1/8
a The following bridging stent-grafts or adjuncts were deployed: AVE Stent, Medtronic Vascular, Santa Rosa, CA, USA; Luminexx Stent, CR Bard, Inc. Tempe, AZ, USA; Fluency Plus
Vascular Stent-Graft, CR Bard, Tempe, AZ, USA; Advanta V12, Atrium Medical, Hudson NH, USA; Jomed Stent-graft, Abbot Vascular Devices, Rangendingen, Germany; Genesis Balloon
Expandable Stent Graft, Cordis, Great Lakes, NJ, USA.
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Table 5 Complications and secondary interventions.
Author, year Morbidity IIA
Dissection
Type I
endoleak
Type II
endoleak
Type III
endoleak
Post-o ive
re-inte ions
Patients with buttock claudication
or sexual dysfunction following IBD
occlusion, as proportion of the
total number of patients with
post-operative IBD occlusion
Dias/Malina
et al,
2008/200623,25
1/22 TIA 1/22 0 2/23 at discharge
1/23 at 1 month
1/22 4/22
1 sten f EIA for
asymp ic kinking
1 exte from AAA
graft i A for type
III end
1 fem moral
cross- fter IBD
occlus
1 IIA s raft
extens
3/6 (buttock claudication)
Haulon/Green
berg et al,
2007/200621 24
0 1/52 0 6/52 at discharge
5/46 at 1 month
5/31 at 6 months
1/21 at
12 months
0/2 at 24 months
0 3/52
2 thro sis for
occlus tortuous
EIA co teral to
IBD
1 thro sis for
occlus EIA
ipsilat o
occlud D
6/6 (buttock claudication)
Ziegler et al,
200729
1/46
Subarachnoid
bleeding
0 0 0 0 0
1 intra tive
throm s and
angiop to
occlud D, which
recana
1 occl IBD
recana
sponta sly
1/4 (buttock claudication)
Serracino-Inglott
et al, 200726
2/8 groin
lymphocoeles
0 0 1/8 0 0 0/1
Tielliu et al,
200927
1/27 pneumonia
1/27 EIA rupture
0 0 0 0 0 1/3 (buttock claudication)
(continued on next page)
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Table 5 (contin )
Author, year Morbidity IIA
Dissection
Type I
endoleak
Type II
endoleak
Type III
endoleak
Post-operative
re-interventions
Patients with buttock claudication
or sexual dysfunction following IBD
occlusion, as proportion of the
total number of patients with
post-operative IBD occlusion
Verzini et al,
200928
1/32 atrial
fibrillation
1/32 pulmonary
embolism
1/32 renal
failure requiring
dialysis
0 1/32 0 1/32 5/322 thrombectomy
for EIA occlusion
1 femoral
artery repair for
pseudoaneurysm
at access site
1 secondary IIA stent
for type I endoleak
at distal IBD sealing
zone
1 interposition
endograft for type
III endoleak at IIA
branch/IIA
stent interface
0/2
Cambridge
Vascular Unit
(unpublished
2009
0 0 0 1/8 0 0 1/2 (buttock claudication)
292
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EVAR with Iliac Branch-Graft Device 293were associated with sac expansion. The type I endoleak
occurred at the distal sealing zone of the IBD and was
managed endovascularly with an additional stent-graft.27
Both cases of type III endoleak occurred at the junction of
the IIA limb of the IBD with its main body,22,27 and these
were also managed with an interposition endovascular
stent-graft.
There was a low rate of post-operative re-intervention,
with 12 patients requiring re-intervention across all series
(Table 5). There were 5 EIA occlusions (Table 5). Three of
these cases were managed with thrombolysis23 and two
were managed with thrombectomy.27 Extension of the
endograft into the EIA has been shown to increase the risk
of iliac limb occlusion after EVAR31e33 and this is therefore
a particular hazard with IBD deployment, although two of
the five EIA occlusions occurred contralateral to the IBD in
a tortuous native EIA.23Implications for further research
Further research is required to identify the subset of
patients at greatest risk of complications following IBD use,
including EIA occlusion, IBD branch occlusion, IBD endoleak
and the need for re-intervention. This is likely to require
multi-centre or registry data, incorporating morphological
assessment, to enable the development of a risk stratifi-
cation model to inform patient selection for IBD. Patients
with aortoiliac or solitary CIA aneurysms require morpho-
logical study to further identify the proportion that is
anatomically suitable for IBD, using risk-stratified indica-
tions for use. The existing literature suggests that up to 52%
of these patients may not be suitable for IBD use,26
although no validated objective criteria for IBD use have
yet been derived and studied.
The development of endoleak following IIA embolisation
is included in the standardised reporting criteria after
EVAR, though no consensus criteria have been outlined for
the reporting of complications following IBD use.21 Agreed
definitions should be produced for the standardised
reporting of complications following the deployment of
IBD. For example, the post-operative penile-brachial
pressure index has been suggested as an objective marker
of impotence following IBD occlusion27. Only one study has
been conducted to directly compare EVAR in patients
undergoing IIA embolisation with those undergoing IIA
revascularisation with IBD.27 There has been no compara-
tive assessment of quality of life, cost-effectiveness or
long-term outcomes; and a randomised trial might there-
fore be useful. There are no data to compare the outcomes
of the HBE device compared to the ZBIS device. Surgeons’
preference appears to be the main distinguishing factor at
present. The helical device may allow more physiological
flow, though no clinical data are available to confirm this
suggestion. The Fluency stent-graft (Bard, Phoenix, AZ,
USA) may be more suitable for use with the HBE device as it
is self-expanding and conformable whereas the Atrium
stent (Atrium Medical, Hudson NH, USA) has been used with
the ZBIS straight side-branch IBD as it is balloon-expand-
able and less flexible; there are no data regarding these
combinations and these are issues to be addressed in
future studies.Cost-effectiveness
It has been shown that hypogastric artery embolisation is
achievable at a cost of approximately $470.34 Undoubtedly,
IBD is a costly technique. The use of Zenith Bifurcated Iliac
Side (ZBIS) device (Cook Inc., Bloomington, IN) adds $6000 to
the cost of standard EVAR with the Zenith endograft,
excluding the additional cost of the bridging stent. Further-
more, EVAR is already associated with greater costs
compared to openAAA repair.35 The cost-effectiveness of IBD
devices is open to question, and this confirms the need for
cautious patient selection. Young patients with high activity
levels at high risk of manifesting symptomatic pelvic
ischaemia may gain most from IBD use. A formal cost-effec-
tiveness appraisal is needed.
Conclusion
IBD procedures may be performed with high technical
success rates and are associated with encouraging mid-term
patency of IIA in selected patients. However, a significant re-
occlusion rate has occurred in existing series, with require-
ment for re-intervention in these cases. Formalised risk
stratification and morphological data are required to iden-
tify the group of patients who will benefit most from EVAR
featuring IBD. Cost-effectiveness appraisals are needed for
this technique.
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